Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 69.59% is in line with its 5-year average of 69.61%, around the middle of its 5-year range (62.80%–77.40%).
0.15% above its 12-month average of 69.48%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 70.97%.
GROSS MARGIN
69.59%
GROSS MARGIN AVG TTM
69.48%
GROSS MARGIN AVG 3Y
67.73%
GROSS MARGIN AVG 5Y
69.61%
GROSS MARGIN AVG 10Y
73.48%
GROSS MARGIN AVG 15Y
75.13%
GROSS MARGIN AVG 20Y
75.45%
CURRENT VS TTM AVG
+0.15%
CURRENT VS 3Y AVG
+2.75%
CURRENT VS 5Y AVG
-0.03%
CURRENT VS 10Y AVG
-5.30%
CURRENT VS 15Y AVG
-7.37%
CURRENT VS 20Y AVG
-7.77%
SECTOR MEDIAN · HEALTHCARE
38.44%
median of 674 covered companies
CURRENT VS SECTOR MEDIAN
+81.04%
vs the sector median at left
Orthofix Medical Inc.
Market Cap
$383.34M
Gross Margin
69.59%
TTM Avg
69.48%
3Y Avg
67.73%
5Y Avg
69.61%
Market Cap
$379.87M
Gross Margin
95.50%
TTM Avg
97.75%
3Y Avg
98.88%
5Y Avg
1.50%
Market Cap
$389.64M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
40.00%
Market Cap
$374.07M
Gross Margin
25.47%
TTM Avg
27.02%
3Y Avg
15.55%
5Y Avg
5.84%
Market Cap
$398.05M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$398.58M
Gross Margin
68.83%
TTM Avg
69.91%
3Y Avg
69.67%
5Y Avg
69.68%
Market Cap
$365.97M
Gross Margin
99.87%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
83.33%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $383.34M | 69.59% | 69.48% | 67.73% | 69.61% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $379.87M | 95.50% | 97.75% | 98.88% | 1.50% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $389.64M | 0.00% | 0.00% | 25.00% | 40.00% |
| Canopy Growth Corporation (CGC)vs › | $374.07M | 25.47% | 27.02% | 15.55% | 5.84% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $398.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| Myriad Genetics, Inc. (MYGN)vs › | $398.58M | 68.83% | 69.91% | 69.67% | 69.68% |
| Opus Genetics, Inc. (IRD)vs › | $365.97M | 99.87% | 100.00% | 100.00% | 83.33% |
| Carlsmed, Inc. (CARL)vs › | $402.34M | 76.63% | 74.56% | 73.66% | 73.66% |
| Ocugen, Inc. (OCGN)vs › | $359.46M | 45.86% | 48.66% | 71.42% | -2398.51% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $358.68M | 98.15% | 96.49% | 98.25% | 98.83% |
Gross Margin
69.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 70.97% |
| 2026-03-31 | 70.94% |
| 2025-12-31 | 64.59% |
| 2025-09-30 | 72.23% |
| 2025-06-30 | 68.69% |
| 2025-03-31 | 62.80% |
| 2024-12-31 | 69.02% |
| 2024-09-30 | 68.69% |
| 2024-06-30 | 67.84% |
| 2024-03-31 | 67.46% |
| 2023-12-31 | 68.17% |
| 2023-09-30 | 65.09% |
| 2023-06-30 | 63.93% |
| 2023-03-31 | 62.97% |
| 2022-12-31 | 72.96% |
| 2022-09-30 | 73.18% |
| 2022-06-30 | 73.24% |
| 2022-03-31 | 73.39% |
| 2021-12-31 | 73.41% |
| 2021-09-30 | 74.82% |
| 2021-06-30 | 77.40% |
| 2021-03-31 | 75.46% |
| 2020-12-31 | 75.28% |
| 2020-09-30 | 76.35% |
| 2020-06-30 | 68.32% |
| 2020-03-31 | 77.67% |
| 2019-12-31 | 78.44% |
| 2019-09-30 | 78.07% |
| 2019-06-30 | 77.72% |
| 2019-03-31 | 78.27% |
| 2018-12-31 | 78.84% |
| 2018-09-30 | 78.50% |
| 2018-06-30 | 79.53% |
| 2018-03-31 | 77.79% |
| 2017-12-31 | 79.84% |
| 2017-09-30 | 77.47% |
| 2017-06-30 | 78.73% |
| 2017-03-31 | 78.02% |
| 2016-12-31 | 78.51% |
| 2016-09-30 | 79.82% |
| 2016-06-30 | 78.37% |
| 2016-03-31 | 77.57% |
| 2015-12-31 | 79.53% |
| 2015-09-30 | 76.41% |
| 2015-06-30 | 78.30% |
| 2015-03-31 | 78.46% |
| 2014-12-31 | 78.60% |
| 2014-09-30 | 74.98% |
| 2014-06-30 | 74.83% |
| 2014-03-31 | 77.67% |
| 2013-12-31 | 69.36% |
| 2013-09-30 | 74.21% |
| 2013-06-30 | 79.40% |
| 2013-03-31 | 77.36% |
| 2012-12-31 | 83.48% |
| 2012-09-30 | 80.50% |
| 2012-06-30 | 80.19% |
| 2012-03-31 | 77.03% |
| 2011-12-31 | 76.83% |
| 2011-09-30 | 75.11% |
| 2011-06-30 | 75.83% |
| 2011-03-31 | 76.03% |
| 2010-12-31 | 77.28% |
| 2010-09-30 | 76.77% |
| 2010-06-30 | 76.14% |
| 2010-03-31 | 76.45% |
| 2009-12-31 | 74.48% |
| 2009-09-30 | 76.32% |
| 2009-06-30 | 73.17% |
| 2009-03-31 | 74.56% |
| 2008-12-31 | 73.75% |
| 2008-09-30 | 62.88% |
| 2008-06-30 | 73.05% |
| 2008-03-31 | 73.26% |
| 2007-12-31 | 73.23% |
| 2007-09-30 | 74.62% |
| 2007-06-30 | 73.24% |
| 2007-03-31 | 73.69% |
| 2006-12-31 | 74.20% |
| 2006-09-30 | 74.80% |
| 2006-06-30 | 74.98% |
| 2006-03-31 | 73.55% |
| 2005-12-31 | 72.69% |
| 2005-09-30 | 73.36% |
| 2005-06-30 | 73.88% |
| 2005-03-31 | 73.10% |
| 2004-12-31 | 72.35% |
| 2004-09-30 | 72.61% |
| 2004-06-30 | 72.18% |
| 2004-03-31 | 72.37% |
| 2003-12-31 | 75.31% |
| 2003-09-30 | 75.65% |
| 2003-06-30 | 74.77% |
| 2003-03-31 | 73.88% |
| 2002-12-31 | 73.64% |
| 2002-09-30 | 75.36% |
